Current Opinion in Pharmacology, Neuroendocrine regulation and behavior
In chemotherapy-induced organ toxicity mitigation
Sahar K.
Ali
Scholar“Research focused on Chemotherapy-induced organ toxicity mitigation and adjacent fields.”
7
H-index
110
Citations
Sahar has not officially claimed their profile. If you are Sahar, claim it free.
Claim Your Profile
Pioneer
LOCKED

Pathfinder
LOCKED

Scholar
EARNED

Innovator
LOCKED

Inventor
LOCKED

Catalyst
LOCKED

Expert
UPGRADE
What I study
ahar K. Ali is a researcher working on Chemotherapy-induced organ toxicity mitigation. A fuller summary will appear once they update their profile.
Publication output and reach
Sahar's work has been cited 110 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
Topics
Recent publications
11 worksTissue and Cell, Chemotherapy-induced organ toxicity mitigation
Tissue and Cell, Drug-Induced Hepatotoxicity and Protection
Naunyn-Schmiedeberg s Archives of Pharmacology, Chemotherapy-induced organ toxicity mitigation
Pharmaceutics, Nigella sativa pharmacological applications
Pharmaceuticals, Diet and metabolism studies
Egyptian Academic Journal of Biological Sciences. D, Histology and Histochemistry, Liver Disease Diagnosis and Treatment
Archives of Biochemistry and Biophysics, Mesenchymal stem cell research
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Sahar?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Free to claim · takes a minute to verify it’s you